title: Hollow fiber membrane modification with functional zwitterionic macromolecules for improved thromboresistance in artificial lungs.
abstract: Respiratory assist devices seek optimized performance in terms of gas transfer efficiency and thromboresistance to minimize device size and reduce complications associated with inadequate blood biocompatibility. The exchange of gas with blood occurs at the surface of the hollow fiber membranes (HFMs) used in these devices. In this study, three zwitterionic macromolecules were attached to HFM surfaces to putatively improve thromboresistance: (1) carboxyl-functionalized zwitterionic phosphorylcholine (PC) and (2) sulfobetaine (SB) macromolecules (mPC or mSB-COOH) prepared by a simple thiol-ene radical polymerization and (3) a low-molecular weight sulfobetaine (SB)-co-methacrylic acid (MA) block copolymer (SBMAb-COOH) prepared by reversible addition-fragmentation chain transfer (RAFT) polymerization. Each macromolecule type was covalently immobilized on an aminated commercial HFM (Celg-A) by a condensation reaction, and HFM surface composition changes were analyzed by X-ray photoelectron spectroscopy. Thrombotic deposition on the HFMs was investigated after contact with ovine blood in vitro. The removal of CO2 by the HFMs was also evaluated using a model respiratory assistance device. The HFMs conjugated with zwitterionic macromolecules (Celg-mPC, Celg-mSB, and Celg-SBMAb) showed expected increases in phosphorus or sulfur surface content. Celg-mPC and Celg-SBMAb experienced rates of platelet deposition significantly lower than those of unmodified (Celg-A, >95% reduction) and heparin-coated (>88% reduction) control HFMs. Smaller reductions were seen with Celg-mSB. The CO2 removal rate for Celg-SBMAb HFMs remained comparable to that of Celg-A. In contrast, the rate of removal of CO2 for heparin-coated HFMs was significantly reduced. The results demonstrate a promising approach to modifying HFMs using zwitterionic macromolecules for artificial lung devices with improved thromboresistance without degradation of gas transfer.
authors: McGowan Institute for Regenerative Medicine and Departments of ‡Surgery, §Bioengineering, ∥Critical Care Medicine, and ⊥Chemical and Petroleum Engineering, University of Pittsburgh , Pittsburgh, Pennsylvania 15219, United States.
authors: Sang-Ho
authors: SH
authors: Ye
authors: David T
authors: DT
authors: Arazawa
authors: Yang
authors: Y
authors: Zhu
authors: Venkat
authors: V
authors: Shankarraman
authors: Alexander D
authors: AD
authors: Malkin
authors: Jeremy D
authors: JD
authors: Kimmel
authors: Lara J
authors: LJ
authors: Gamble
authors: Kazuhiko
authors: K
authors: Ishihara
authors: William J
authors: WJ
authors: Federspiel
authors: William R
authors: WR
authors: Wagner
mesh_terms: D046911:Macromolecular Substances / Q000737:chemistry*; D008567:Membranes, Artificial; D015394:Molecular Structure; D010316:Particle Size; D016062:Porosity; D013499:Surface Properties
chemical_list: D046911:Macromolecular Substances; D008567:Membranes, Artificial